AstraZeneca Suspends $270M UK Commitment Months After Scrapping Vaccine Facility
AstraZeneca in January also stopped its $610 million plans to construct a vaccine R&D and manufacturing site in the U.K.
AstraZeneca Suspends $270M UK Commitment Months After Scrapping Vaccine Facility Read More »
